Results 171 to 180 of about 115,605 (312)

The sandwiched pleural effusion

open access: yesLung India, 2019
Uma Maheswari Krishnaswamy   +5 more
openaire   +3 more sources

Respiratory improvement of aspiration pneumonia using high‐flow oxygen therapy in a cat

open access: yesVeterinary Record Case Reports, EarlyView.
Abstract A 13‐year‐old neutered male cat was presented with acute paraparesis and severe thoracolumbar pain. Magnetic resonance imaging revealed an extradural paraspinal mass compressing the spinal cord. Surgery was performed, but 20 h post‐operatively, the cat developed severe respiratory distress consistent with aspiration pneumonia.
Vanessa Neubert   +2 more
wiley   +1 more source

Iatrogenic pulsus alternans in a dog undergoing median sternotomy

open access: yesVeterinary Record Case Reports, EarlyView.
Abstract A 6‐year‐old, 21.8 kg, female, spayed Siberian husky was referred for management of a spontaneous bilateral pneumothorax, due to a ruptured pulmonary bleb. During surgery, sterile saline was instilled on three occasions in order to locate the damaged lung tissue and ensure complete ligation.
Marie‐Line Doï   +2 more
wiley   +1 more source

Dynamic changes of serum cytokines and their prognostic values in patients with hepatocellular carcinoma treated by thermal ablation

open access: yesSurgical Practice, EarlyView.
Abstract Background Thermal ablation is effective for early‐stage hepatocellular carcinoma (HCC). It can induce a host immune response through dynamic changes in serum cytokines. It is unknown whether this host immune response correlates with tumour recurrence.
Kelvin K. C. Ng   +3 more
wiley   +1 more source

Real‐World Survival Outcomes of Patients With High PD‐L1 Advanced NSCLC Who Received Chemoimmunotherapy Versus Immunotherapy

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Are two drugs better than one in advanced NSCLC? ABSTRACT Background Randomized studies have demonstrated superior overall survival (OS) of pembrolizumab (pembro), both alone and in combination with chemotherapy (chemo) over chemo alone in patients with programmed cell death ligand‐1 (PD‐L1) ≥ 50% advanced non–small cell lung cancer (NSCLC).
Junipearl Cheng   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy